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1. INTRODUCTION 
1.1. Introduction to the Immune System 
1.1.1. Innate Immunity 
A functioning immune system is an essential characteristic for the 
integrity of any living organism. In the case of the human body, the 
immune system is the collection and meaningful interaction of tissues, 
cells and molecules that participate in the various defense mechanisms. 
It can be divided in 2 parts, the innate immunity and the adaptive 
immunity. The innate immunity, like the word ”innate” means, is a natural 
defense against microbial infections, which is always present, ready to 
recognize and eliminate microbes. The adaptive immunity, unlike the 
innate immunity, learns to recognize microbes as pathogens only after 
having had contact with them. Epithelial barriers, phagocytes 
(neutrophils, monocytes, and macrophages), natural killer cells, the 
complement system, and some cytokines and plasma proteins build up 
the innate immunity. One shared characteristic of innate immunity is that 
they can create an immune response to microbes and then give an 
adequate protection until the adaptive immunity develops its full 
potential. 
It was believed for many years that innate immunity is rather nonspecific, 
weak, uncomplicated, and is not very effective against most infections. 
Intense research in the field of innate immunity over the last years has 
shown that innate immunity, like the adaptive immunity, shows specificity 
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toward microbes and is a powerful early defense mechanism which can 
keep the infections under control or even eliminate them before 
activation of adaptive immunity occurs. Moreover, it is now understood 
that interactions in innate immunity areas complicated as the adaptive 
immune response, or even more complicated. 
As a part of innate immunity, the neutrophils circulate in the human blood 
along with monocytes and other immune cells and are recruited to sites 
of infection. There they recognize microbes and eliminate them by 
phagocytosis and other mechanisms. Neutrophils, also called 
polymorphonuclear leukocytes or PMNs, are abundant leukocytes in the 
blood with the amount of 4,000 to 10,000 per µL blood in a healthy adult 
male. During an immune response, cytokines are produced to stimulate 
proliferation and maturation of neutrophils. Neutrophils are the first cell 
type to be activated in response to most infections, especially infections 
caused by a bacterial or fungal origin. After having been recruited to 
extravascular sites of infection and inflammation, neutrophil activation 
leads to two important steps in the creation of a meaningful immune 
response. On the one hand, phagocytosis leads to immediate control of 
inflammation; on the other hand, secretion of cytokines leads to 
activation of the adaptive immune response and therefore has important 
regulatory functions. 
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1.1.2. Communication between Innate and Adaptive Immunity 
As stated, not only is there early defense by innate immunity, but also is 
there a close communication between innate and adaptive immunity. 
Regulatory cytokines are one major tool of such communication. Innate 
immunity enhances the effectiveness of adaptive immunity in response 
to microbes while combating with them. Also, the adaptive immune 
response often uses similar mechanisms in order to eliminate microbes. 
The most basic mechanism to do so is through the major 
histocompatibility complex (MHC) molecules, also referred to as human 
leukocyte antigen (HLA) molecules in humans. These molecules have a 
vital role in the complex immunological dialogue that occurs between T 
cells and other cells of the body. MHC molecules, which are anchored in 
the cell membrane, constantly display short polypeptides to T cells. Via 
the T cell receptors (TCR) T-cells can recognize these short peptides, 
and depending on the presents or abstinence of co-stimulatory signals 
the T cells differentiate between "self"- and "non-self"- protein. The 
MHC-TCR interaction enables that T cells should ignore self-peptides 
while reacting appropriately to the foreign peptides, which are then 
considered antigens. If recognized as an antigen by CD4+ T cells, also 
called TH cells, these cells will activate the B cells and macrophages, and 
if recognized by CD8+ T cells, direct killing will follow from activation of 
CD8+ T cells.  
The subtype of TH cells, TH1 cell, helps macrophages to enhance the 
microbial killing, and another subtype, TH2 cells, helps eosinophils to 
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combat with helminthes, which are generally too large to be engulfed by 
macrophages. Furthermore, both subtypes of TH cells induce the B cells 
to release antibodies, which help macrophages to recognize microbes. 
Conversely, the antigen-presenting cells (APC) of innate immunity play 
an essential role in proliferation and maturation for T cells and B cells. 
A full-force immune response usually requires the activation of B cells 
via the B cell receptor (BCR) and T cells via the MHC-TCR interaction. 
This duality creates a system of "checks and balances". Without some 
limitation to the activation cascade, the immune system has the potential 
to run amok and to cause harm to the body, such as a state generally 
known as autoimmune disease. The balance of immune system can be 
achieved by so called regulatory T cells, which, if activated appropriately, 
suppress the immune response to a meaningful extent(Schwartz 2005). 
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1.1.3. Pattern Recognition Receptors 
Microbial molecules recognized by innate immunity share highly 
conserved molecular structures, called molecular patterns. These 
patterns are essential for the microbes’ integrity and are therefore 
expressed despite millions of years of evolutionary pressure. The 
receptors of innate immunity which are able to recognize these 
molecular patterns are called pattern recognition receptors, or PRRs. 
Molecular patterns are found in bacteria, fungi, and viruses, but 
essentially not in mammalian cells. For instance, phagocytes express 
receptors for bacterial liposaccharide, which is present in many bacterial 
species, but is not produced by mammalian cells. Other receptors of 
phagocytes recognize terminal mannose residues on glycoproteins; 
many bacterial glycoproteins have terminal mannose, but mammalian 
glycoproteins end with sialic acid or N-acetylgalactosamine. Phagocytes 
recognize and respond to double- stranded RNA (dsRNA), which is 
found in many viruses but not in mammalian cells. A common structure 
found in bacterial DNA is unmethylated CpG motives. These are 
generally not found in mammalian cells. Therefore, such molecular 
patterns are also called pathogen-associated molecular patterns, or 
PAMPs. 
The PRRs consist of several main families depending on their structure. 
These include the large families of membrane-bound Toll-like receptors 
(TLRs) and cytoplasmic NOD-like receptors (NLRs) as well as endocytic 
PRRs which promote the attachment, engulfment and destruction of 
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microorganisms by phagocytes, without relaying an intracellular signal. 
Some PRRs recognize carbohydrates, such as mannose receptors of 
macrophages, glucan receptors on all phagocytes; other PRRs, like 
scavenger receptors which recognize charged ligands, are found on all 
phagocytes and mediate removal of apoptotic cells(Platt, da Silva et al. 
1999). 
PRRs can be separated by localization in three different types: 
membrane-bound, cytoplasmic, and secreted. The mannose receptor, 
one of the membrane-bound PRRs, is a PRR primarily present on the 
surface of macrophages and dendritic cells. The mannose receptor 
belongs to the multi-lectin receptor protein group and, provides a link 
between innate and adaptive immunity(Apostolopoulos and McKenzie 
2001). It recognizes and binds to repeated mannose units on the 
surfaces of infectious agents and its activation triggers endocytosis and 
phagocytosis of the microbes via the complement system. The TLRs, 
like the mannose receptor, are also membrane-bound and mediate the 
recognition of extracellular or endosomal PAMPs (Beutler, Jiang et al. 
2006). TLRs were first discovered in the Drosophila fruit fly and are 
known to trigger a series of mechanisms leading to the synthesis and 
secretion of cytokines and activation of other host defense programs that 
are crucial to the development of innate or adaptive immune responses. 
At present, TLRs have been found in many species. In mammals, these 
receptors have been assigned numbers 1 to 11 (TLR1-TLR11). 
Interaction of TLRs with their specific PAMP induces NFκB signaling and 
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mitogen-activated protein kinase (MAPK)pathway in most cases and 
therefore the secretion of pro-inflammatory cytokines and co-stimulatory 
molecules. Molecules that are released following TLR activation give 
signals to other cells of the immune system. Therefore, TLRs are a key 
element of both innate immunity and adaptive immunity (Doyle and 
O'Neill 2006). Table 1 shows an overview of the different TLRs and their 
ligands. 
Together with the NOD-like receptors, which are cytoplasmic proteins 
that may have a variety of functions in the regulation of inflammatory and 
apoptotic responses and have been found in the mammalian genome, 
some RNA helicases (RHs) mediate intracellular recognition of viral 
double-stranded and single-stranded RNA and in turn recruit factors via 
twin N-terminal caspase recruitment domains, or CARD domains, to 
activate antiviral gene programs. Three such helicases have been 
described in mammals: retinoic acid inducible gene I (RIG-I) and 
melanoma differentiation associated gene-5 (MDA5) (recognizing 
5’-triphosphate RNA (3pRNA) and double-stranded RNA (dsRNA), 
respectively), which activate antiviral signaling, and LGP2, which 
appears to act as a dominant-negative inhibitor(Komuro and Horvath 
2006). In addition to NLRs and RHs, absent in melanoma-2 (AIM2) is 
estimated to be a 39 kDa protein encoded by the AIM2 gene and is a 
newly identified gene that is not  expressed in a human melanoma cell 
line and is localized primarily in the cytoplasm (Choubey, Walter et al. 
2000). Cytoplasmic double-stranded DNA (dsDNA) triggers cell death 
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and secretion of the pro-inflammatory cytokine IL-1β in macrophages. 
Recent reports now describe the mechanism underlying this 
observation(Fernandes-Alnemri, Yu et al. 2009). Upon sensing of DNA, 
the HIN-200(hematopoietic interferon-inducible nuclear antigens with 
200 amino acid repeats) family member,AIM2, triggers the assembly of 
the inflammasome, culminating in caspase-1 activation, IL-1β maturation 
and pyroptotic cell death (Schroder, Muruve et al. 2009). 
A number of PRRs do not remain associated with the cell that produces 
them. Complement receptors, collectins, pentraxin proteins such as 
serum amyloid and C-reactive protein, lipid transferases, peptidoglycan 
recognition proteins (PGRs) and the leucine-rich repeat (LRR), 
Xa21D(Wang, Ruan et al. 1998) are all secreted proteins. One very 
important collectin is mannan-binding lectin (MBL), a major PRR of the 
innate immune system that binds to a wide range of bacteria, viruses, 
fungi and protozoa. MBL predominantly recognizes certain sugar groups 
on the surface of microorganisms but also binds phospholipids, nucleic 
acids and non-glycosylated proteins(Dommett, Klein et al. 2006). 
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TLR PAMP Origin Reference 
TLR1 Cooperate with TLR2   
TLR2 Lipoproteins gram-positive 
bacteria 
(Takeuchi, Hoshino et 
al. 1999) 
 Zymosan yeast (Ozinsky, Smith et al. 
2000; Ozinsky, 
Underhill et al. 2000) 
 Macrophage-activatin
g lipopeptide 2 
(MALP-2) 
mycoplasma (Takeuchi, Hoshino et 
al. 2000) 
 Lipoarabinomannan 
(LAM) 
mycobacteria (Underhill, Ozinsky et 
al. 1999) 
TLR3 dsRNA virus (Alexopoulou, Holt et 
al. 2001) 
TLR4 LPS gram-negative 
bacteria 
(Poltorak, Smirnova et 
al. 1998) 
 Protein F RSV (Kurt-Jones, Popova et 
al. 2000) 
 Hsp 60 host (Ohashi, Burkart et al. 
2000) 
 Hyaluronan host (Termeer, Benedix et 
al. 2002) 
 Fibronectin host (Okamura, Watari et al. 
2001) 
TLR5 Flagellin different kinds of 
gram-negative 
bacteria 
(Hayashi, Smith et al. 
2001) 
TLR6 Cooperate with TLR2  (Takeuchi, Kawai et al. 
1999) 
TLR7 ssRNA, dsRNA, and 
guanosine analog 
virus (Hemmi, Kaisho et al. 
2002) 
TLR8 ssRNA, dsRNA, and 
guanosine analog 
virus (Jurk, Heil et al. 2002) 
TLR9 CpG-motive Bacteria,virus (Hemmi, Takeuchi et 
al. 2000) 
TLR10 unknown unknown  
TLR11 Profilin and 
profilin-like protein 
Toxoplasma 
gondii 
(Yarovinsky, Zhang et 
al. 2005) 
Table 1 Human TLRs and their ligands  
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1.1.4. Immunostimulation via RNA and DNA molecules 
Immunostimulatory RNAs (isRNAs) are known to generate a potent 
immune response and are currently under intense investigation for new 
antiviral and anticancer treatment strategies. They were originally 
identified due to their immunostimulatory sequences as ligands for TLR7 
and TLR8. It has recently become apparent that in addition to stimulation 
of TLRs, certain chemical modifications on the 5’-ends of small 
interfering RNA (siRNA) can induce similar effects as isRNAs via 
receptors in the cytosol, such as RIG-I. RIG-I (also known as DDX58) 
was identified as a candidate for cytoplasmic viral detection. RIG-I is 
compromised of two N terminal caspase-recruitment domains (CARDs), 
followed by a DExD/H box RNA helicase domain. Together with MDA5 
(also known as helicard or IFIH1) and LGP2, RIG-I forms the RLH family 
based on their high similarities among their helicase domains. RLHs 
interact with dsRNAs through their helicase domain, and dsRNA 
stimulation induces their ATP catalytic activity. The N terminal CARDs 
are responsible for activating downstream signaling pathways that 
mediate dsRNA-induced type I interferon (IFN) production(Hornung, 
Ellegast et al. 2006). 3pRNA is one ligand for RIG-I(Hornung, Ellegast et 
al. 2006; Pichlmair, Schulz et al. 2006). RNAs from some viruses are 5’ 
triphosporylated and uncapped and are therefore recognized by RIG-I. 
MDA5, in contrast, is thought to response to uncapped, 5’ unmodified 
dsRNA such as polyinosinic:polycytidylic acid (poly(I:C))(Kato, Takeuchi 
et al. 2006).Through this mechanism, both RIG-I and MDA5 were 
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observed to induce the production of interferon (IFN-β1) (Figure 1, 
(Baccala, Hoebe et al. 2007)). 
 
Figure 1.  RIG-I and MDA5 induce the production of IFN-β1 
Engagement of the cytosolic RNA helicases RIG-I (for example, by 3pRNA) and 
MDA5 (for example, by poly(I:C)) induces conformational changes that allow 
CARD-mediated homotypic interaction between RIG-I/MDA5 and the 
mitochondrial adaptor IPS-1. The ensuing TBK1/IKK? , IKK???  and MAPK 
signaling induces IRF3, AP-1 and NF- ? B translocation, and Ifnb1 
transcription.(Baccala, Hoebe et al. 2007)(TANK-binding kinase 1(TBK1), 
IkappaB-related kinase (IKK)) 
 
Recent research showed that AIM2 is a sensor for cytoplasmic DNA in 
macrophages that trigger antiviral and/or inflammatory responses, which 
forms an inflammasome with the ligand and apoptosis-associated 
speck-like protein (ASC) to activate caspase-1.(Hornung, Ablasser et al. 
2009)The HIN200 domain of AIM2 binds to DNA, whereas the pyrin 
domain (but not that of the other PYHIN family members) associates with 
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the adaptor molecule ASC (containing a caspase activation and 
recruitment domain) to activate both NF-κB and caspase-1. Knockdown 
of AIM2 abrogates caspase-1 activation in response to cytoplasmic 
dsDNA and the dsDNA vaccinia virus. 
 
1.2. Objectives 
There is reasonable hope that siRNAs with immunostimulatory potential 
will lead to jet more advanced antiviral and anticancer therapy. One 
interesting approach is to stimulate RIG-I with modified siRNA in order to 
cause simultaneous specific gene knock-down via RNA interference 
(RNAi) and immunostimulation. E. g., Poeck et al. showed simultaneous 
knockdown of Bcl 2 and IFN induction to be superior to either therapy 
alone in an in vivo melanoma mouse model (Poeck, Besch et al. 2008). 
However, little is known about possible side effects of such therapies. 
For example, stimulation of off target cells such as human neutrophils 
may limit the therapeutic potential of isRNAs. Human neutrophils are a 
substantial part of the innate immune system and recognize pathogen 
through PRRs. They are usually the first cell population to be involved in 
an immune response and modulate subsequent immune response not 
only due to their potential to directly eliminate pathogens by 
phagocytosis but also by induction of regulatory cytokines such as 
interleukin 8 (IL-8). It is known that human neutrophils express TLR8 but 
not TLR3 and TLR7. In a recent publication, Ekman and Cardell showed 
that neutrophils express functional active NLRs(Ekman and Cardell 
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2010). NLRs are PRRs and have been implicated in several 
immunological diseases such as Crohn’s disease and asthma, but the 
knowledge of their role in neutrophils is still limited. It is entirely unknown 
if human neutrophils express functional active RIG-I or MDA5 and if this 
results in a limitation of 3pRNA-based therapeutic approaches. The aim 
of this study was therefore to analyze the expression of RIG-I and MDA5 
in human neutrophils and human promyelocytic leukemia cells 
(HL60cells), a tumor cell line with similar characteristics as neutrophils 
and to compare this to the expression of TLRs. Further we want to 
investigate the potential of human neutrophils to be activated by 3pRNA. 
Since AIM2can trigger antiviral and inflammatory responses by binding 
to cytoplasmic DNA in macrophages similar to PRRs, another objective 
was to analyze the expression of AIM2 in neutrophils and whether they 
can be activated by dsDNA mimicking cytoplasmic DNA. 
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2. MATERIALS AND METHODS 
2.1. Material 
2.1.1. Isolated human neutrophils 
Due to the short ex vivo lifetime of human neutrophils, the neutrophils 
were freshly isolated prior to each experiment. Neutrophils from the 
peripheral blood of healthy volunteers were chosen and kept under 4°C 
in phosphate buffered saline (PBS) or Roswell Park Memorial 
Institute(RPMI) solution for further use to slow down the apoptotic 
process of isolated neutrophils. No additional cytokines were given to the 
culture medium. 
 
2.1.2. Cell lines 
The HL-60 (also called neutrophil-like cell line) cell line is a leukemic cell 
line, which was originally derived from a 36-year old woman with 
promyelocytic leukemia. HL-60 proliferates continuously in culture 
medium supplemented with fetal bovine serum (FBS), L-glutamine, 
HEPES and antibiotic chemicals. The doubling time is about 36–48 
hours.HL-60 cells are predominantly neutrophilic promyelocytes 
(Gallagher, Collins et al. 1979). 
When treated with dimethyl sulfoxide (DMSO) or retinoic acid, these 
cells differentiate to a cell type with strong similarities to mature human 
granulocytes(Jacob, Leport et al. 2002). In our study, we exclusively 
used DMSO for differentiation of HL60 cells. These differentiated, 
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mature HL60 cells resemble human neutrophils and have been a 
resource for continuous granulocyte research. 
As stated above, human neutrophils go into apoptosis quickly after 
isolation and therefore cultured HL-60 cell line provides a continuous 
source of granulocyte-like cells, which serve excellently for studying the 
physiologic and immunologic characters of human neutrophils. 
 
2.1.3. Chemicals 
General use for isolation of human neutrophils: 
Name Detail 
Ficoll-Paque® Plus by Amersham Biosciences 
Dulbecco's PBS (1x)  without Ca & Mg, by PAA 
Erylysis Buffer ice-cold, with 155 mM NH4Cl, 10 mM KHCO3, 0.1 mM 
EDTA, pH 7.4 
 
Chemicals for quantitative Real-time PCR: 
Name Detail 
TRI Reagent® ice-cold, by Ambion 
Ampuwa RNase-free, by Abnova 
UltraPure RNase-free and DNase-free, by Invitrogen 
Ethanol 70% and 100% bySigma Aldrich 
Isoprorpanol by Sigma-Aldrich 
Chloroform by Sigma-Aldrich 
β-Mercaptoethanol by Sigma-Aldrich 
RNeasy Mini Kit with RLT-Buffer, RPE-Buffer, RNase-free Water, 
RW1-Buffer, by QIAGEN 
RNase-Free DNase Set with 1500 units RNase-free DNase I, RNase-free Buffer 
RDD, and RNase-free water by QIAGEN 
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Random Hexamer by Abgene 
5x1st strand buffer by Invitrogen 
0,1µM DTT by Invitrogen 
10mM dNTPs by Invitrogen 
RNase H by Invitrogen 
SuperScript II by Invitrogen 
SYBR ® GREEN by Abgene, Thermo Scientific 
 
Chemicals for Confocal microscopy and 3pRNA labeling: 
Name Detail 
NHS-Fluorescein 5-(and 6-)carboxyfluorescein, succinimidyl ester by Thermo 
Scientific 
DMSO Dimethyl sulfoxide by Sigma-Aldrich 
Borate buffer BupH™ Borate Buffer Packs, 50mM, pH 8.5 by Thermo 
Scientific 
Dye Removal 
Column 
Fluorescent Dye Removal Columns by Thermo Scientific 
DAPI 4’,6-diamidino-2-phenylindole, dihydrochloride by Invitrogen 
NGS Normal goat serum by SouthernBiotech 
 
Miscellaneous: 
Name Detail 
FACS Flow BD FACSFlow™ Sheath Fluid from BD Biosciences 
FACS Rinse BD FACS Rinse Solution from BD Biosciences 
FACS Clean BD FACS Clean Solution from BD Biosciences 
MACS Running Buffer autoMACS™ Running Buffer.by Miltenyi Biotec 
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2.1.4. Antibodies 
Name Specificity Clone Host Target Conjugation Manufacturer 
Anti-AIM2  AIM2 polyclonal rabbit human none Abcam 
Anti-CD11b CD11b ICRF44 mouse human APC BioLegend 
Anti-MDA5 MDA5 polyclonal rabbit human none Abcam 
Anti-RIG-I RIG-I polyclonal rabbit human none SantaCruz 
Anti-TLR8 TLR8 44C143 mouse human PE Imegenex 
Anti-TLR9 TLR9 eB72-1665 rat human PE eBioscience 
Anti-CD16 CD16 3G8 mouse human APC BioLegend 
Anti-CD62L CD62L DREG-56 mouse human FITC BioLegend 
Goat anti 
Rabbit IgG 
2ndAb* 
rabbit IgG polyclonal goat rabbit FITC Abcam 
Alexa Fluor® 
555 Goat anti 
Rabbit 2ndAb 
rabbit IgG polyclonal goat rabbit Alexa Fluor® 
555 
Invitrogen 
CD16 
MicroBeads 
CD16     Miltenyi 
Biotec 
Human 
Interferon-β 
ELISA Kit 
Interferon-β     TFB 
Human 
TNF-α 
Immunoassay 
Kit 
TNF-α     Invitrogen 
* The goat anti rabbit IgG 2nd antibody was served as secondary antibody for the 
primary antibodies, like anti-AIM2, anti-MDA5, and anti-RIG-I antibodies in FACS 
analysis. 
** The Alexa Fluorp555 Goat anti Rabbit 2ndantibody was served as secondary antibody 
foranti-RIG-I antibody in confocal microscopy. 
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2.1.5. Stimulants 
The following stimulants were used in the stimulation assays on 
neutrophils and the HL60 cells. 
Miscellaneous Stimulants: 
Stimulant Target Detail 
E.coli K12 LPS TLR4 Gram-negative bacteria 
Poly(I:C) TLR3/MDA5 Synthetic analog of dsRNA 
ODN2006(type B) TLR9 Synthetic oligonucleotides containing 
unmethylated CpG dinucleotides, 
5’-TCGTCGTTTTGTCGTTTTGTCGTT-3’ 
(Phosphorothioate bases) 
ssRNA40 TLR8 20-mer phosphorothioate protected 
single-stranded RNA oilgonucleotide 
containing a GU-rich sequence, complexed 
with LyoVecTM 
5’-GCCCGUCUGUUGUGUGACUC-3’ 
(Phosphorothioate bases) 
R848 TLR7/8 an imidazoquinoline compound 
 
Stimulants synthesized by Eurogentec: 
Stimulant Target Detail 
Poly-A-Control  Sequence: 
5’-AAAAAAAAAAAAAAAAAAA-3’ 
isRNA9.2s-unmodified TLR7/8 Sequence: 
5’-AGCUUAACCUGUCCUUCA-3’ 
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Stimulants synthesized by Ambion: 
Stimulant Target Detail 
siRNA(OHBcl2_2) RIG-I Sequence(Sense): 
5’-GCAUGCGACCUCUGUUUGAUU-3’ 
Sequence(Antisense): 
5’-UCAAACAGAGGUCGCAUGCUU-3’ 
siRNA-Mismatch 
(Control) 
 Sequence(Sense): 
5’-UUCUCCGAACGUGUCACGUUU-3’ 
Sequence(Antisense): 
5’-ACGUGACACGUUCGGAGAAUU-3’ 
 
Self-synthesized stimulants: 
Stimulant Target Detail 
3pRNA RIG-I Sequence(Sense): 
5’-pppGCAUGCGACCUCUGUUUGAUU-3’ 
Sequence(Antisense): 
5’-pppUCAAACAGAGGUCGCAUGCUU-3’ 
3pRNA 
(Control) 
 Sequence(Sense): 
5’-pppUUCUCCGAACGUGUCACGUUU-3’ 
Sequence(Antisense): 
5’-pppACGUGACACGUUCGGAGAAUU-3’ 
 
Stimulant produced by Sigma-Aldrich: 
Stimulant Target receptor  Detail 
Poly(dA-dT) • Poly(dA-dT) RIG-I/AIM2 Double-stranded DNA 
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2.1.6. Materials for the HL60 Cells Culture 
As medium, RPMI 1640 READY MIX with L-Glutamine was mixed with 
10% FBS but without antibiotics for the culture of HL60 cells. 
 
2.1.7. Primer for Real-time-PCR 
Oligo- 
name 
Sequence 
Forward Reverse 
TLR1 CTGGTATCTCAGGATGGTGTGC TTGGAGTTCTTCTAAGGGTATGTTCC 
TLR2 GCCTCTCCAAGGAAGAATCC TCCTGTTGTTGGACAGGTCA 
TLR3 TCCCAAGCCTTCAACGACTG TGGGTGAAGGAGAGCTATCCACA 
TLR4 AAGCCGAAAGGTGATTGTTG CTGAGCAGGGTCTTCTCCAC 
TLR5 TCGAGCCCCTACAAGGGAA CACTGAGACTCTGCTATACAAGCTA 
TLR6 CTATTGTTAAAAGCTTCCATTTTGT ACCTGAAGCTCAGCGATGTAGTTC 
TLR7 TTACCTGGATGGAAACCAGCTAC TCAAGGCTGAGAAGCTGTAAGCTA 
TLR8 GAGAGCCGAGACAAAAACGTTC TGTCGATGATGGCCAATCC 
TLR9 TGGTGTTGAAGGACAGTTCTCTC CACTCGGAGGTTTCCCAGC 
TLR10 GAAAGGTTCCCGCAGACTTG TGGAGTTGAAAAAGGAGGTTATAG 
MDA5 ATGTGGCAGCAAGAGCATCC GGTAAGGCCTGAGCTGGAGTT 
AIM2 GCTTTTGGCAAAACGTCTTCA TCAGCTTGACTTAGTGGCTTTGG 
RIG-I TGACTGGACGTGGCAAAACA TGCCGGGAGGGTCATTC 
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2.2. Cellular Immunology Methods 
2.2.1. Isolation of Human Neutrophils 
Ficoll-Paque® Plus Method: 
Human neutrophils were isolated by Ficoll-Paque density gradient 
centrifugation from the EDTA treated blood of healthy volunteers. As 
showed in the figure 2, the phase of the erythrocytes and the 
granulocytes on the bottom was kept after centrifugation. Then the 
erythrocytes were lysed by the Erylysis buffer and removed by further 
centrifugations.  
 
Figure 2. Ficoll-Paquep Plus Centrifugation(GE Healthcare Life Sciences) 
 
 
Further Isolation with MACS® cell separation: 
In some experiments, neutrophils were additionally positive-selected 
with anti-CD16 microbeads (Magnetic Cell Sorting, Miltenyi Biotec). With 
the magnetic labeling on target cells, they were kept in the column within 
a strong magnetic field of the separator while the sample was passing 
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through the column. After the sample passed through the column, the 
column was removed from the magnetic separator. The labeled target 
cells were then eluted from the column. Evaluation of the neutrophil 
population with fluorescence activated cell sorting (FACS) showed purity 
of >85-88% (SEM 2.5%) for isolation with Ficoll-Hypaque density 
gradient centrifugation alone and 93-95% (SEM 2%) for additional cell 
sorting with microbeads. 
 
2.2.1. Cell culture of HL60 cells 
The HL60 cells were kept in 37°C laminar air flow cabinet within 25 mL 
total volume of RPMI (10%FBS) medium and were split every 3 days. In 
the interest of the physiological functions of HL60 cells and due to the 
similarity between DMSO-treated HL60 and human neutrophils, the cells 
were separated into 2 cell lines. One of the cell lines was treated with 
1.25% DMSO, and the other one not. After 5 days treatment with DMSO 
the treated cells and the untreated cells underwent the same FACS 
analysis of the TLR8, TLR9, MDA5, AIM2, and RIG-I and also the 
quantitative PCR. 
 
2.2.2. Flow cytometry 
Flow cytometry is a technology that simultaneously measures and then 
analyzes multiple physical characteristics of single cells as they ﬂow in a 
ﬂuid stream through a beam of light. The properties measured include a 
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particle’s relative size, relative granularity or internal complexity, and 
relative ﬂuorescence intensity. These characteristics are determined 
using an optical-to-electronic coupling system that records how the cell 
or particle scatters incident laser light and emits ﬂuorescence. Several 
detectors are used for that purpose. One is directed in line with the light 
beam, the forward scatter, which measures the size of the cell. Several 
detectors are perpendicular to the light beam. The side scatter measures 
the intracellular granularity. Separate fluorescence channels detect 
fluorescent light associated with the particle. The surface antigens are 
marked with the correspondent labeled antibody to a fluorescence dye 
(direct immunofluorescence) or a first unlabeled antibody would be 
coupled with a second fluorescence-labeled antibody (indirect 
immunofluorescence). 
List mode data are collected on each particle or event. The 
characteristics or parameters of each event are based on its light 
scattering and ﬂuorescent properties. The data are collected and stored 
in the computer. This data can be analyzed to provide information about 
subpopulations within the sample (Figure 3, Introduction to flow 
cytometry Manual NO.11-11032-01April, 2000 BD Biosciences). 
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Figure 3. The detection of fluorescence turns into computer signals 
Scattered and emitted light signals are converted to electronic pulses that can be 
processed by the computer. Further detail is described in text. 
 
Flow cytometry is routinely used in the diagnosis of health disorders, 
especially blood cancers. It provides a great way to analyze human 
neutrophils. In our experiments, flow cytometric data were obtained on a 
FACSCalibur flow cytometer and analyzed with CellQuest software (BD 
Biosciences). Staining was performed following standard procedures to 
detect the proteins in the cytoplasm and on the cell surface of human 
neutrophils. The anti-CD11bantibody which is conjugated with 
allophycocyanin (APC) was used in a membranous staining to 
distinguish the neutrophils from the other white blood cells. Mouse anti 
human TLR8 and rat anti human TLR9 antibodies which are conjugated 
with phycoerythrin (PE) were used for staining TLR8, TLR9.Rabbit anti 
human MDA5, rabbit anti human AIM2, and rabbitanti human RIG-I 
antibodies were with the assistance of 2nd antibodies, goat anti-rabbit 2nd 
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antibody to complete the staining of MDA5, AIM2, and RIG-I.The 2nd 
antibody was conjugated with fluorescein isothiocyanate (FITC). 
For the cytoplasmic detection of the receptors, the IntraPrep Kit 
(Beckman Coulter) was used to pre-incubate the cells with Reagent 1 of 
this kit, which contains formaldehyde for the fixation of the cells. Then 
the cells were permeabilized with Reagent 2 of the kit, which contains 
saponine, and stained to detect the receptors in the cells. For the 
membranous staining of the receptors, cells were only stained with the 
antibodies and then fixed with 2% paraformaldehyde for the flow 
cytometric analysis. 
In the flow cytometric analysis, the antibody labeled sample was always 
measured alone with its isotype control labeled sample to obtain the 
mean fluorescence intensity ratio (MFI ratio), which will be explained 
under the section on statistical analysis. 
 
2.2.3. Confocal Microscopy 
Compared to conventional wide field optical microscopy,confocal 
microscopy is a relatively new optical imaging technique, which is able to 
control the depth of detected field and reduction of background 
information by using a spatial filtering technique to eliminate out-of-focus 
light. The laser-induced fluorescence light will pass through a pinhole 
and be screened before reaching the detector (Figure 4). The 
information of a focus plane can be re-constructed into 3D Information. 
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Because of its better resolution than conventional fluorescence 
microscopy, it is now widely used in cell immunology for live or fixed 
cells. 
 
 
Figure 4. Basic setup of a confocal microscope 
Light from the laser is scanned across the specimen by the scanning mirrors. 
Optical sectioning occurs as the light passes through a pinhole on its way to the 
detector (Confocal Microscopy, D Semwogerere, USA). 
The isolated neutrophils were first fixed with 4% paraformaldehyde and 
blocked with 10% normal goat serum (NGS) in diluent. Then the rabbit 
anti human RIG-I antibody as the primary antibody was used to localize 
RIG-I in neutrophils together with secondary antibody of goat anti rabbit 
antibody which was labeled with Alexa Fluorо® 555. For labeling cell 
nuclei in human neutrophils, we chose 4,6-diamidino-2-phenylindole 
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(DAPI) which can diffuse easily through the cell membrane and be used 
both in live cells and fixed cells. 
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2.3. Molecular Methods 
2.3.1. RNA Isolation 
The isolated polymorphonuclear leukocytes were lysed and 
homogenized in the Tri Reagent at room temperature. The suspension 
was layer separated with chloroform. The upper clear phase of solution, 
in which the RNA was dissolved, was precipitated and cleaned with 
100% Isopropanol and 70% Ethanol, and the RNA was again dissolved 
in the Ampuwa (RNase-free water) at 55°C. 
 
2.3.2. cDNA Synthesis 
In our experiments, we used complementary DNA (cDNA) synthesis to 
analyze the relative amount and the existence of mRNA for each protein 
that we are interested in, the TLRs, MDA5, AIM2, and RIG-I. 
For cDNA synthesis, to each 2µg isolated RNA sample from human 
neutrophils of each healthy volunteer random hexamer primers were 
added, which contain every possible 6 bases single strand of DNA and 
can therefore hybridize anywhere on the RNA, and the sample was 
incubated at 70°C for the denaturation of the RNAs and the primers. 
Then the strand buffer, 0.1µM DTT, and 10mM dNTP were added into 
the samples, and by adding the reverse transcriptase, superscript II 
cDNA was produced. Finally, the mRNA templates were hydrolyzed by 
RHase H. 
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2.3.3. Polymerase Chain Reaction 
Polymerase chain reaction (PCR) is a technique in molecular biology 
capable to produce a great amount of a particular DNA copies using only 
a single or few copies of a piece of DNA by serial changes of 
temperature and several repeated cycles of DNA amplification. In each 
cycle, DNA will be heated to break its double-stranded structure and be 
cooled down again, and primers with sequences complementary to the 
target region can bind. Together with assistance of DNA polymerase the 
selected DNA sequences will be amplified. This process is repeated in a 
thermocycle several times creating exponential amplification of the 
desired DNA sequences. In our study, we used this technique in order to 
quantify the mRNA expression in human neutrophils by producing the 
cDNA of mRNA and analyzing cDNA in quantitative Real-time PCR. 
With the Mastercycler® ep realplex (Eppendorf) the Real-time 
quantitative PCR (qPCR) was set to a specific amount of DNA product at 
which the amplification of each sample should be broken down. This 
process is called kinetic detection (Figure 5). As a reference gene 
(housekeeping gene) we chose the gene of TATA-Box binding protein 
(TBP), which is abundant in eukaryotic cells and shows good stability by 
qPCR (Nygard, Jorgensen et al. 2007). We used previously described 
primer sequences of TLR1 to TLR10, MDA5, AIM2, and RIG-I(Hayashi, 
Means et al. 2003). The cDNA was quantitatively analyzed referring to 
the housekeeping gene. The statistical analysis will be described in a 
later section. 
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Figure 5. PCR: kinetic vs. endpoint detection (Eppendorf) 
A plot of the quantity of amplicon DNA over time; in real-time PCR we are only 
concerned with amplification during the exponential phase of amplification, as 
accurate quantification of DNA is not possible at the plateau. 
 
2.4. Stimulation of cells 
2.4.1. Stimulation of Toll-like receptors 
All TLR-ligands were titrated to defined optimal stimulating 
concentrations and underwent 40 minutes of stimulation with 37°C of 
incubation in the different cell types analyzed in the study. Cells were 
generally stimulated with LPS from Escherichia coli. Poly(I:C) was used 
for stimulation of TLR3, and for stimulation of TLR7 and TLR8, and we 
used R-848and CpG 2006 (5’-TCGTCGTTTTGTCGTTTTGTCGTT-3’) to 
stimulate the TLR9. 
In order to have a further functional view on TLR7 and TLR8 in our cells, 
we stimulated the cells with our previously described isRNA 9.2 
antisense (5’-UUGAAGGACAGGUUAAGCUdTdT-3’), which was 
synthesized by Eurogentec Germany GmbH. For better transfection into 
32 
 
the cells, we have complexed nucleic acid by using the poly-cationic 
polypeptide, poly-L-arginine (P7762 by Sigma-Aldrich). As a control, we 
used non-stimulatory poly-A-RNA repeats, also purchased at 
Eurogentec Germany GmbH. 
 
2.4.2. Stimulation of RIG-I 
Similar to the stimulation with TLR-ligands, 3pRNA and small interfering 
RNA used as ligands for RIG-I, as well as dsDNA with poly (AT) repeat 
used as a ligand for AIM2 and poly(I:C) as a ligand for MDA5 were all 
titrated to defined optimal stimulating conditions in the stimulation assay. 
For generation of in vitro transcribed dsRNA, the DNA templates of the 
sense and antisense strands were transcribed for 6 hours in separate 
reactions using PCR. An extra guanosine was present at the 5’ end to 
both the sense and the antisense strands in order to transcribe with T7 
RNA polymerase. The reactions were then mixed and incubated 
overnight at 37°C to anneal the transcribed RNA strands. The DNA 
template was digested using DNase-I (Ambion) and subsequently RNAs 
were purified by phenol:chloroform extraction and alcohol precipitation. 
Excess salts and NTPs were removed by passing the RNAs through a 
Mini Quick SpinTM Oligo Column (Roche). In order to test the 
immunostimulatory potential of 3pRNA on human neutrophils, 3pRNA 
was first complexed with lipofectamine and then given into cultures of 
human neutrophils to incubate at 37°Cfor 40 minutes.  
33 
 
After stimulation, the expression of CD62L and CD11b on human 
neutrophils was analyzed in FACS to compare stimulation intensity of 
each stimulant. For the cell staining in FACS, we used mouse anti 
human CD11b antibodies (conjugated with APC) and mouse anti human 
CD62L antibodies (conjugated with FITC). For instance, siRNA with the 
same nucleotide sequence like 3pRNA was used to compare the 
stimulation intensity with 3pRNA.Additionally, TNF-α production was 
measured with ELISA. 
 
2.5. Statistical Analysis 
Quantitative Real-time PCR with normalization with TBP genes 
In the quantitative Real-time PCR, the TBP genes were chosen to 
normalize the values of our proteins. With the kinetic detection of 
Mastercycler® ep realplex (Eppendorf) we set a stop point of 
amplification of the polymerase chain reaction which is supposed to be 
“X” copies of DNA fragments. Each primer of our protein underwent 
amplification until reaching this end point, and the hardware counted the 
cycles of reactions each sample needed to reach this end point. For 
instance, the TBP genes need 20 cycles to reach the end point, and the 
sample needs 18 cycles. With this information, one can obtain the 
relative amount of genes of this sample on cDNA of our volunteer with 
the following equation referring to the TBP: 
The relative amount of genes = 2 - (cycles of sample gene - cycles of TBP gene) 
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In this case, the sample gene in the cDNA sample is present fourfold 
compared to the TBP gene. With this equation we obtained the relative 
quantitative gene expression of our proteins in cDNA sample which are 
related to the mRNA expression. 
 
Mean Fluorescence Intensity Ratio was used for FACS analysis: 
In order to avoid the interference of antibody staining with unspecific 
isotype control staining, we chose the mean fluorescence intensity 
ratio(MFI ratio), an established immunological analysis method(Chwae, 
Lee et al. 2007; Buhtoiarov, Neal et al. 2011)to analyze the values of our 
FACS analysis with the following equation. 
 
Student’s paired two-tailed t test was used to analyze data 
Data are presented as means± S.E.. The statistical significance of 
differences was determined by Student’s paired two-tailed t test. In all 
tests, differences were considered significant at p< 0.05. 
MFI ratio= 
(MFI of the antibody) 
(MFI of the isotype control) 
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3. RESULTS 
3.1. Expression of Toll-like Receptors, MDA5, AIM2 and RIG-I 
in human neutrophils 
3.1.1. Expression of mRNA 
It is known that human neutrophils express TLRs (Hayashi, Means et al. 
2003). Recently, it was shown that neutrophils express NOD-like 
receptors and can be activated by these receptors (Ekman and Cardell 
2009). However, in human neutrophils, there are hardly any detailed 
reports on the expression of RIG-I, AIM2 and MDA5. Therefore, we 
aimed to establish a profile for these receptors in neutrophils by 
analyzing both messenger RNA (mRNA) and protein expression. 
In order to analyze mRNA expression of TLRs, MDA5, AIM2 and RIG-I 
we performed quantitative real-time PCR. In quantitative real-time PCR 
analysis, all the values showed are relative to gene expression of a 
typical housekeeping gene, in our case TATA-binding protein (TBP). In 
this analysis, TBP and all genes that code for protein investigated here 
were amplified to specific an amount, which is called kinetic detection.  
Analysis of TLRs-coding mRNA showed significant expression for all 
TLRs except TLR3 and TLR7.The mRNA of TLR1 and TLR2 were 
expressed most. With respect to the mRNA of other TLRs capable of 
detecting nucleic acids, TLR8 was expressed most (20-fold compared to 
TLR9, which was low but significant, and 3-fold compared to 
LPS-binding-receptor TLR4, Figure 6).The mRNA coding for RIG-I, AIM2, 
and MDA5showed low but significant expression in human neutrophils, 
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and expression for all was significantly higher when compared to TLR3 
and TLR7, higher when compared to TLR9 but significantly lower than 
expression for TLR8.  
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Figure 6. Expression of mRNA for TLRs, RIG-I and MDA5 in granulocytes 
Isolated granulocytes were obtained from healthy volunteers and analyzed by 
real-time PCR for the expression profile of TLRs, RIG-I, AIM2 and MDA5. TBP 
was used as a reference for expression. As mentioned in the text, a kinetic 
detection was used to measure the relative quantitative expression of each 
protein. The mean s S.E. of 6 donors is shown. *, p< 0.05.  
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3.1.2. FACS Analysis of Protein Expression 
After having established an mRNA expression profile of neutrophils by 
real-time PCR, in the next step the actual protein expression was 
analyzed with FACS and compared to mRNA expression. After isolation 
of neutrophils, cells were stained with specific antibodies for both 
intracellular and membranous expression of TLR8, TLR9, MDA5, AIM2 
and RIG-I.  
We found that TLR8, MDA5, AIM2, and RIG-I but not TLR9 were 
expressed both intracellularly and on the cell surface in human 
neutrophils. This is in contrast to data from qPCR because here we 
observed low but relevant expression of mRNA for TLR9 (see Figure 7).  
When comparing intracellular expression to expression on the cell 
surface, we found similar expression for TLR8. MDA5was mostly 
expressed intracellularly, but significant expression of MDA5 was 
observed additionally on the cell surface. Expression of AIM2 was 
observed on the cell surface and intracellularly to a lower degree, which 
was not statistically significant. Interestingly, expression on the cell 
surface for RIG-I was 6-fold higher compared to the intracellular 
expression.  
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Figure 7. Protein Expression of TLR8, TLR9, AIM2, RIG-I and MDA5 in 
granulocytes 
Expression of TLR8, TLR9, RIG-I and MDA5in human neutrophils from healthy 
volunteers was analyzed by FACS without any type of stimulation. The mean 
fluorescence intensity ratio was used to show the fluorescence strength of each 
protein relative to its control sample. In order to see the distribution of each 
protein, within human neutrophils, cells were stained intracellularly and for cell 
surface expression. The mean s S.E. of 3 donors is shown. *, p< 0.05. 
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3.1.3. Subcellular Localization 
Because our findings in FACS analysis showed significantly more 
expression of RIG-I on the cell surface in comparison to intracellular 
expression, we analyzed the subcellular localization of TLR8 and RIG-I 
with confocal microscopy (Figure 8). When analyzing the subcellular 
localization of TLR8, we found mostly intracellular expression. In the 
subcellular localization of RIG-I we found expression both intracellularly 
and on the cell surface which confirmed our findings from FACS 
analysis.  
 
 
Figure 8. RIG-I shows both intracellular and membranous expression in 
confocal microscopy 
Human neutrophils were isolated from healthy volunteers. The isolated 
neutrophils were fixed with 4% paraformaldehyde and blocked with 10% NGS in 
diluent. Then the RIG-Iwas treated with antibodies and labeled with Alexa 
Fluor͕p 555 leading to the red stain in the pictures. Cellಬs nuclei in human 
neutrophils were labeled with DAPI(blue color), and FITC-Con A (green) was 
used for staining the cytoplasm. 
Merge ConA
RIG-I DAPI
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3.1.4. Expression of RIG-I in murine neutrophils 
The high expression of RIG-I on the cell surface on human neutrophils 
was further analyzed by comparing these findings to the expression of 
RIG-I in murine neutrophils. Murine neutrophils were isolated from bone 
marrow by ficoll isolation and stained with specific antibodies against 
RIG-I as described for human neutrophils. 
Compared to human neutrophils no expression was observed on the cell 
surface of murine neutrophils, but high expression was seen in the 
cytoplasm (see figure 9). 
 
Figure 9. Expression of RIG-I in murine PMNs 
The expression of RIG-I in human (above) and murine (below) PMNs. 
Histograms are show for both intracellular and cell surface expression. Isotype 
control is shown as in blue for human cells and in red for murine cells. MFI = 
mean fluorescence intensity. 
cytosolic
Human PMNs
RIG-I FITC (MFI)
membranous
Mouse PMNs
membranouscytosolic
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3.2. Expression of Toll-like Receptors, MDA5, AIM2 and RIG-I 
in HL60 cells 
3.2.1. Expression of mRNA 
PMNs are challenging to cultivate and have very short survival ex vivo. 
Alternative strategies have recently been described in order to 
investigate this important cell population (Klinker, Wenzel-Seifert et al. 
1996). The neutrophil-like cell line (HL-60) is a powerful alternative to 
analyze neutrophilic granulocytes(Collins, Ruscetti et al. 1979). This 
cancer cell line was originally isolated from a patient with acute 
myelogenic leukemia and has similar markers and characteristics as 
human granulocytes, especially after further differentiation with DMSO 
(Gallagher, Collins et al. 1979; Jacob, Leport et al. 2002). 
With the same primers used to analyze the mRNA expression of TLRs, 
RIG-I, MDA5 and AIM2of human neutrophils, both untreated HL60 cells 
and HL60 cells pretreated with 5 days of DMSO maturation were 
analyzed with PCR. When compared to the mRNA profile of human 
neutrophils, the profile ofHL60 cells showed many similarities but also 
differences. Similarities were, especially seen in comparison to the 
DMSO-treated HL60 cells.  
The difference between human neutrophils and DMSO-treated as well 
as untreated HL60 cells was that the HL60 cells express mRNA of TLR3 
but not TLR5,and only marginal levels of TLR10. However, when 
comparing TLR3 expression between untreated and DMSO-treated 
HL60 cells, we observed significant reduction of expression for 
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DMSO-treated cells. Like in the human neutrophils, TLR7 is not 
expressed in the HL60 cell lines. Likewise, in human granulocytes 
expression of TLR1 and TLR2 was the highest. Expression of TLR6, 
expressed in a robust manner in mature human granulocytes, was 
expressed high solely in DMSO-stimulated HL60 cells. Surprisingly, and 
in sharp contrast to mature granulocytes, TLR8 was expressed low in 
untreated HL60 cells and marginally in DMSO-treated cells. TLR9, 
expressed marginally in mature granulocytes, showed significant 
expression in both DMSO-treated and untreated HL60 cells.  
The untreated HL60 cells further showed a very low expression of RIG-I 
and MDA5, but their expression was increased after treatment with 
DMSO and was then higher than TLR9 comparable to mature human 
neutrophils. 
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Figure 10. Expression of mRNA for TLRs, AIM2, RIG-I and MDA5 on 
HL-60 cells  
HL60 cells were either cultured untreated or treated with DMSO for 5 days and 
analyzed by real-time PCR for the expression profile of TLRs, RIG-I, AIM2 and 
MDA5. TBP was used as a reference for expression. As mentioned before, a 
kinetic detection was used to measure the relative quantitative expression of 
each protein. *, p< 0.05. 
 
45 
 
3.2.2. Protein Expression of HL60 cells 
Similar to our approach in granulocytes, we additionally analyzed protein 
expression of TLR8, TLR9, RIG-I, MDA5 and AIM2 for both 
DMSO-treated and untreated HL60 cells. We stained these proteins by 
specific antibodies both for intracellular expression and expression on 
the cell surface and analyzed the cells by FACS.  
HL60 cells, similar to human neutrophils, express TLR8, MDA5, AIM2, 
and RIG-I but not TLR9.TLR8 was expressed both in the cytoplasm and 
on the surface of cells in untreated HL60 cells express, and there was no 
significant difference between these two.  
Untreated HL60 cells showed expression of MDA5 in both compartments, 
but there was significantly more expression on the cell surface, which is 
in contrast to the results found in human granulocytes. However, after 
the maturation with DMSO, expression of surface MDA5wasalmost 
entirely suppressed. High expression of intracellular MDA5 was part of 
the characteristic profile observed for human granulocytes.  
This suppression observed for expression of MDA5 after maturation of 
HL60 cells was observed in a similar way for the expression of AIM2 and 
RIG-I, even though these two proteins where expressed to a significantly 
lower degree in HL60 cells that were not treated with DMSO. 
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Figure 11. Protein Expression of TLRs, AIM2, RIG-I and MDA5 on HL-60 
cells 
TLR8, TLR9, MDA5, AIM2, and RIG-I were analyzed in untreated and 
DMSO-treated HL-60 cells with FACS. The mean fluorescence intensity ratio 
was used to show the fluorescence strength of each protein relative to their 
control sample. In order to appreciate the subcellular distribution of each protein, 
similar to the experiments performed in human neutrophils, HL60 cells were 
stained intracellularly and for cell surface expression.*, p< 0.05. 
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3.3. Stimulation of human neutrophils 
3.3.1. Stimulation with immunostimulatory RNA 
In our previous results we observed expression of TLR8, MDA5, AIM2, 
and RIG-I in human neutrophils. In the next step, we now stimulated 
these receptors with their respective ligands in order to analyze their 
functionality. Human neutrophils were isolated as described above and 
stimulated with CpG 2006 (TLR9), dsDNA (AIM2), LPS (TLR4), R848 
(TLR7/8), isRNA 9.2 sense complexed with Poly-L-Arginine (TLR8), 
Poly-L-Arginine alone (control), 3pRNA complexed with lipofectamine 
(intracellular RIG-I), 3pRNA (extracellular RIG-I) and lipofectamine alone 
(control), as well as siRNA (control) in different concentration. 
After 40 minutes of stimulation at 37°C human neutrophils were 
analyzed regarding their expression of CD62L and CD11b on the cell 
surface. Up-regulation of CD11b and simultaneous down-regulation of 
CD62L are well established markers of neutrophil activation(Wittmann, 
Rothe et al. 2004).  
LPS, which is known to bind TLR4, showed strong activation of 
neutrophils characterized by both up-regulation of CD11b and 
down-regulation of CD62L at the lowest concentration used (0,1µg/mL) 
and served as a positive control. Activation observed by R848, which 
activates TLR8, was of similar characteristic in that it caused 
up-regulation of CD11b, down-regulation of CD62L and showed activity 
at low concentration, although it was somewhat weaker compared to 
LPS. Also, while LPS showed its maximal activating effect on human 
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neutrophils with a concentration of0,1µg/mL, activation caused by R848 
could be increased with higher concentrations. 
The other ligand used for stimulation of TLR8 was isRNA 
9.2sensecomplexed with poly-L-Arginine. We saw no up-regulation of 
CD11b for this ligand but down-regulation of CD62L for both the complex 
and the poly-L-Arginine alone. The maximal activation caused by isRNA 
9.2s complexed with poly-L-Arginine at a concentration of 4µg/mL was 
even weaker than the activation caused by poly-L-Arginine alone (Figure 
12 (A) and (B)). 
For the stimulation of the low but reproducible and constant expressed 
RIG-I in human neutrophils, we designed 3pRNA,which contains a 
triphosphate chemical modification at the 5’-end of both stands (see 
material and methods for details). For controls, we used double-stranded 
siRNA with the exact same sequence but without the triphosphate 
modification. Both siRNA and 3pRNA were complexed with 
lipofectamine for intracellular activation. The stimulation curve of 
lipofectamine only represented its amount in each titrated concentration 
of complexed solution with stimulants. We saw no significant activation 
of human neutrophils by this ligand in comparing to the stimulation curve 
of to lipofectamine alone (Figure 13 (A) and (B)). 
The dsDNA and CpG, which binds to AIM2 and TLR9, respectively, 
showed no significant activation of human neutrophils. Even though we 
observed some down-regulation of CD62L on the cell surface, we 
observed no up-regulation of CD11b for these stimuli.  
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(A) 
 
(B) 
 
 
Figure 12. Stimulation assay of human neutrophils 
PMNs were isolated and stimulated with LPS, R848, CpG-2006, dsDNA, 
isRNA9.2s (complexed with Poly-L-Arginine), poly-A-RNA (complexed with 
Poly-L-Arginine), and poly-L-Arginine complexion solution in different stimulation 
concentrations.40 minutes after stimulation, expression of both CD62L (A) and 
CD11b (B) were examined by FACS. The mean of 3 donors is shown. *, p< 0.05. 
  
50 
 
(A) 
 
(B) 
 
 
Figure 13. Stimulation assay of human neutrophils 
Granulocytes were isolated and stimulated with LPS, R848, siRNA (complexed 
with lipofectamine) or 3pRNA (complexed with lipofectamine), and lipofectamine 
complexion solution in different stimulation concentrations.40 minutes after 
stimulation, expression of both CD62L (A) and CD11b (B) were examined by 
FACS. The mean of 3 donors is shown. *, p< 0.05. 
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3.3.2. Cytokine production of neutrophils after stimulation 
Having observed both the expression and down-regulation of certain cell 
surface markers characterizing the activation of human neutrophils after 
stimulation of PRRs, we wanted to analyze the cytokine production as an 
additional marker of activation. We isolated neutrophils and stimulated 
neutrophils as described. Cells were stimulated for 40 minutes at 37°C, 
and enzyme-linked immunosorbent assay (ELISA) was performed for 
detection of tumor necrosis factor-alpha (TNF-α) in the supernatants. 
TNF-α is a well-established marker of activation in human neutrophils. 
We did not observe cytokine production of untreated neutrophils or 
stimulation with isRNA, 3pRNA alone or lipofectamine alone, similar to 
the results found in the FACS analysis. There was very low activation 
with 3pRNA complexed with lipofectamine (31pg/mL). The highest 
activation was observed for stimulation with R848 activating 
TLR8.Stimulation with LPS activating TLR4 likewise showed significant 
activation.  
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Figure 14. TNF-α production in human neutrophils after stimulation  
After human neutrophils were isolated and stimulated for 40 minutes as 
described, ELISA was used in order to assess cytokine levels in the 
supernatants. The mean s S.E. of 3 donors is shown. *, p< 0.05. Lipo = 
Lipofectamine 
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3.3.3. Change of Receptor Profile after Stimulation 
It is known that certain PRRs alter their expression after stimulation with 
their respective ligands (Poltorak, Smirnova et al. 1998; Muzio, Bosisio 
et al. 2000; Nomura, Akashi et al. 2000; Visintin, Mazzoni et al. 2001). 
For example, both the expression of TLR7 and TLR9 may be altered 
after stimulation with their ligands (Hornung, Rothenfusser et al. 2002). 
Whether this is true for PRRs in neutrophils is entirely unknown. 
Therefore, in the next step, we assessed the expression profile of TLR8, 
TLR9, AIM2, MDA5, and RIG-I in human neutrophils after activation. 
Neutrophils were isolated as described and stimulated with 
phorbol-myristate-acetate (PMA), a known stimulant of human 
neutrophils (Nishihira and O'Flaherty 1985), at a concentration of 40 
ng/mL at 37°C for 10 minutes. Then, using FACS stain and analysis as 
described above, the expression profile after activation was analyzed.  
The protein expression of TLR8 showed no change in the expression 
profile or the overall level of expression. As in unstimulated human 
neutrophils, we found no expression of TLR9 after stimulation of these 
cells.  
For MDA5 and AIM2 there was no change in the expression profile for 
both the subcellular distribution and the overall level of expression. The 
same holds true for RIG-I, which again was found predominantly on the 
cell surface when compared to intracellular expression.  
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Figure 15. Protein expression after 10 mins stimulation with PMA in 
human neutrophils 
Similar to earlier experiments in unstimulated human neutrophils, protein 
expression of TLR8, TLR9,MDA5, AIM2, and RIG-I was now analyzed with 
FACS for human neutrophils after stimulation for 10 minutes with 40ng/mL of 
PMA at37°C. Mean fluorescence intensity ratio was used to show the 
fluorescence strength of each protein relative to their control sample. Both 
intracellular stains as well as cell surface expression were analyzed. The mean 
s S.E. of six different healthy donors is shown. *, p< 0.05. 
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3.3.4. Colocalization of 3pRNA and RIG-I 
In our previous experiments, we observed significant expression of RIG-I 
in human neutrophils but no activation upon stimulation with its natural 
ligand 3pRNA. We now wanted to investigate the colocalization of the 
receptor and the ligand on both the cell surface and intracellularly in 
order to exclude degradation of the ligand or lack of binding. We isolated 
human neutrophils as described and stimulated them with pre-stained 
3pRNA with NHS-Fluorescein. Then we stained cells as described 
above and analyzed them with confocal microscopy (Figure 16).  
We found that the expression of RIG-I colocalized with the 3pRNAboth 
on the cell surface and intracellularly. Controls using TLR8 ligand R848 
and siRNA without the triphosphate compound showed no colocalization 
with RIG-I(data not shown). 
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Figure 16. Colocalization of 3pRNA with RIG-I in human neutrophils 
In confocal microscopy, 3pRNA was labeled with NHF-Fluorescein to have green 
color. RIG-I was again stained with Alexa Fluor͕p 555 resulting in rot points in 
the pictures. Cell nuclei in human neutrophils were labeled with DAPI to have 
blue color. 
Merge 3p-RNA
RIG-I DAPI
Merge 3p-RNA
RIG-I DAPI
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4. DISCUSSION 
4.1. Overview of our Experimental Findings 
In this study we established the mRNA expression profiles of TLRs (from 
TLR1 to TLR10), MDA5, AIM2, and RIG-I in human neutrophils and 
HL60 cells by using quantitative real-time PCR. Additionally, 
experimental studies were performed on the level of protein expression, 
using both FACS analysis and confocal microscopy.  
With respect to the mRNA level of TLR1 through TLR10, we found no 
expression of TLR3 and TLR7 in human neutrophils, regardless of their 
state of activation. TLR3 was expressed in untreated HL-60 cells but not 
in DMSO-treated cells. As in human neutrophils, TLR7 was not 
expressed in HL-60 cells. We found a high expression of TLR8 in human 
neutrophils, low expression in untreated HL-60 cells and no expression 
of TLR8 in DMSO-treated cells. TLR9 was expressed marginally on 
human neutrophils and low in both untreated and DMSO-treated 
HL-60cells. Therefore, despite the general theory that DMSO-treated 
HL-60 cells resemble many of the characteristics of human neutrophils, 
we found many differences for those PRRs that are capable to be 
activated by nucleic acids such as DNA and RNA. 
There was no protein expression for TLR9 but significant expression of 
TLR8 in human neutrophils and HL60 cells. In addition, TLR8 was 
expressed not only in the cytoplasm but also on the cell surface in these 
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cells and showed no significant difference between cytoplasmic and 
surface expression. 
Along with the TLRs, MDA5, AIM2, and RIG-I were analyzed on both the 
levels of mRNA and protein expression. We saw significant expression 
of MDA5, RIG-I andAIM2 in human neutrophils. We saw no expression 
of RIG-I and MDA5 in untreated HL-60 but significant expression of 
these receptors in DMSO-treated, mature HL-60 cells. Conversely,AIM2 
was expressed on untreated HL60 cells but not in mature HL-60 cells 
MDA5 was found primarily intracellularly for untreated and 
DMSO-treated cells, but expression was found on the cell surface only of 
untreated HL-60 cells. The same held true for the expression of RIG-I 
and AIM2. Confocal microscopy confirmed the expression of RIG-I on 
the cell surface of human neutrophils, and colocalization studies with the 
confocal microscope confirmed the binding of RIG-I with its ligand, 
3pRNA. 
However, despite binding of 3pRNA to its receptor, stimulation of human 
neutrophils with the known RIG-I ligand (3pRNA) did not result in 
activation of human neutrophils. Stimulation with known activators of 
neutrophils such as TLR4 ligand (LPS) and TLR8 ligand (R848) resulted 
in strong up-regulation of CD11b, down-regulation of CD62-L and 
induction of TNF-α. 
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4.2. Interpretation of Data with Respect to the Current 
Literature 
4.2.1. TLRs, MDA5, AIM2, and RIG-I exist in human neutrophils 
Of the 10 known TLRs to date, only TLR3, TLR7, TLR8 and TLR9 are 
capable of recognizing nucleic acid. The expression profile of mRNAs for 
TLRs on human neutrophils has been described by Hayashi et al. and 
Janke et al. Similar to their results; we did not see TLR3 but significant 
TLR8 expression in PMNs. However, in contrast to Hayashi et al. and in 
accordance to Janke et. al., we did not see expression of TLR7 and only 
marginal expression of TLR9. The expression of TLR1, TLR2, TLR4, 
TLR5, and TLR6 showed similar results between our study and the study 
of Hayashi et al. Strong expression of TLR2 and TLR4 was observed by 
Janke et al. These differences may be influenced by the use of different 
primers as well as different reference genes. Instead of TBP, both cited 
investigators choseβ2-microglobulin and β-actin as reference genes, 
respectively. β2-microglobulin and β-actin are abundant genes in 
nucleated cells and expressed far more than TBP. They are both useful 
and frequently used reference gene for quantitative real-time PCR. 
However, as was observed by Nygard et al., TBP is good reference 
genes especially for low abundant transcripts in expression studies.  
In human neutrophils, essentially nothing is known about the expression 
of MDA5, RIG-Ior AIM2. In other immune cells, like macrophages and 
dendritic cells, AIM2 was reported to be expressed predominantly as a 
cytosolic sensor for dsDNA and was essential for inflammasome 
activation in response to Francisella tularensis, vaccinia virus and mouse 
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cytomegalovirus and had a partial role in the sensing of Listeria 
monocytogenes(Fernandes-Alnemri, Yu et al. 2010; Rathinam, Jiang et 
al. 2010). In this study, we demonstrated the existence of AIM2 in human 
neutrophils by using qPCR, FACS analysis and confocal microscopy.  
The expression of RIG-I has been reported for dendritic cells and certain 
mesothelial cells (Hornung, Ellegast et al. 2006; Takeuchi and Akira 
2008; Wornle, Sauter et al. 2009). The presents of RLHs in PMNs and 
the PMN responses upon their activation have not previously been 
described. The typically described location for this receptor is the cytosol. 
In our experiments, in addition to intracellular expression, surprisingly we 
repeatedly observed protein expression on the cell surface. 
One limitation of this study is that the experiments presented here largely 
depend on the specificity of the antibodies used for flow cytometry. 
Therefore, every key result of the presented work was carried out using 
two different specific antibodies with two different binding sites. 
Nevertheless, even though highly unlikely, one can make the legitimate 
argument that our results may possibly be biased or influenced by 
unspecific cross-staining. Therefore, as a continuation of this 
dissertation, we used additional experimental methods including 
subcellular fractionation to further clarify this important aspect. The 
subcellular components were stained for RIG-I or MDA-5 and analyzed 
separately by Western blotting(Berger, Hsieh et al. 2012). As a positive 
control, autologous PBMCs were utilized, which are well known to 
express cytosolic RIG-I and MDA-5. These experiments demonstrated 
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that human neutrophils expressed both RIG-I and MDA-5 with a similar 
molecular mass compared with PBMCs. Remarkably, RIG-I and MDA-5 
in neutrophils were detectable in fractions characteristic for secretory 
vesicles and plasma membranes, whereas the RLH proteins were 
absent in primary/azurophilic, secondary/specific, or tertiary/gelatinase 
granule fractions. Besides secretory vesicles, the proteins were 
detectable in cytosolic fractions. In immune-transmission electron 
microscopy, RIG-I proteins were frequently associated with 
membranous/vesicle-like structures (Berger, Hsieh et al. 2012). 
One of the most interesting findings we made in our study was the fact 
that while RIG-I seems to indeed be expressed primarily on the cell 
surface of human neutrophils, this is not the case for murine neutrophils. 
One possible explanation for cell surface expression of RIG-I in human 
neutrophils could be that this receptor is functioning as a scavenger 
receptor, especially in the light of no observed downstream activation 
after stimulation with the ligand 3pRNA. For example, previous studies 
have shown that innate surface receptors on neutrophils, such as C-C 
chemokine receptor type 5 (CCR5), can act as scavenging receptors 
(Ariel, Fredman et al. 2006). Therefore, surface RIG-I on neutrophils 
could serve as RNA binding and inactivation receptor at sites of 
neutrophilic inflammation. It would not be surprising that such a function 
of RIG-I is not present in the murine system. Despite the close genetic 
similarity between the murine and the human immune system, many 
dissimilarities are describes especially for innate immunity. For example, 
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while detection of bacterial DNA by TLR9 in the human system induces 
large amount of IFN-α, no IL-12 is induced by this pathway, leading to a 
succumbed, insufficient TH-1 immune response. In contrast, in the 
murine system, stimulation of TLR9 leads to full blown, competent TH-1 
immune response including both the induction of IL-12 and IFN-α. 
 
4.2.2. R848 stimulates human neutrophils 
Off-target effects of RNA-based immunostimulatory ligands for TLR7 
and TLR8 on neutrophils has recently been investigated thoroughly by 
Janke et al (Janke, Poth et al. 2009). They stimulated isolated human 
neutrophils with isRNA and R848 and saw activation of neutrophils but 
not eosinophils via TLR8. However, this effect was abolished when the 
RNA-backbone of isRNA consisted not of nuclease-stable 
phosphothioate but of regular phosphodiester bindings. In our 
experiments, we used nuclease unstable isRNA with phoshodiester 
backbone as a control and saw no activation of neutrophils, compared to 
high activation by TLR8ligand (R848). Our findings are therefore in 
accordance with Janke et al. for stimulation of TLR8. Therefore, as 
recognized by Janke et al., small-molecule TLR8 ligands and 
nuclease-stable RNA bear limitations for clinical utility. Similar to the 
results of Janke et al., we did not see any change in the expression 
profile of TLR7 and TLR8, even though the modes of stimulation were 
different. Janke et al. activated cells with IFN-β and then assed TLR 
expression compared to unstimulated cells; we used the known 
63 
 
neutrophil activator PMA. Both molecules are known to cause unspecific, 
general activation in neutrophils. Therefore, results are comparable.  
 
4.2.3. TLR9 activates neutrophils only with pretreatment of GM-CSF 
In the study of Hayashi et al., the authors reported an increased TLR9 
expression in quantitative real-time PCR in human neutrophils and a 
significant response to CpG DNA with induction of IL-8 expression only 
after treatment with granulocyte-macrophage colony-stimulating factor 
(GM-CSF). They also found that CpG DNA was not able to trigger the 
L-Selectin (CD62L) shedding without pre-treatment, which is interpreted 
as one form of activation of neutrophils. In our study, we saw no 
response to CpG2006 if human neutrophils were directly stimulated with 
CpG2006 without prestimulation. These findings suggest that human 
neutrophils need to first be activated to increase expression of TLR9, 
and with higher concentration of translated TLR9 protein human 
neutrophils can finally react to CpG DNA. We pre-treated human 
neutrophils with PMA. However, we did not see any change of protein 
expression of TLR9 in FACS analysis. This is in contrast to Hayashi et al. 
and could be explained by the different stimuli used for pretreatment. 
PMA is thought to cause general activation of neutrophils towards 
respiratory burst, while GM-CSF causes specific induction of the 
maturation process of granulocytes.  
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4.2.4. 3pRNA exhibited no activation of human neutrophils 
In the study of Hornung et al, 3pRNAwas reported as a potent inducer of 
IFN-α in human monocytes. They used in vitro transcription to generate 
a dsRNA oligonucleotide with an overhang of one nucleotide at the 5' 
position. The two single-stranded oligonucleotides and the 
double-stranded oligonucleotide induced comparable levels of IFN-α in 
monocytes. Cleavage of the 5'-overhang (including the 5'-triphosphate) 
of the dsRNA or dephosphorylation of the 5' end completely abrogated 
the IFN response. They also observed that plasmacytoid dendritic cells 
(PDCs), however, showed no decrease in IFN production when 
oligonucleotides were dephosphorylated. Together, the results of 
Hornung et al. suggested that the 5'-triphosphate is at least one 
well-defined structural feature responsible for IFN-α–inducing activity of 
in vitro–transcribed RNA in monocytes and that a 5'-triphosphate confers 
IFN-α–inducing activity to both single-stranded RNA (ssRNA) and 
dsRNA. In addition, they demonstrated a direct binding on RIG-I by 
3pRNA in human embryonic kidney (HEK) 293 cells.  
In the light of these findings, the expression of RIG-I in human 
neutrophils and the functional response of RIG-I on human neutrophils 
were investigated by treating isolated human neutrophils with 3pRNA, 
and expression of surface markers CD62L and CD11b were used as 
markers of neutrophil activation. Even though we found low but 
significant expression of RIG-I on both the protein and mRNA level, we 
observed no activation of human neutrophils by 3pRNA. In addition, we 
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also stimulated human neutrophils with 3pRNA and assessed the 
production of TNF-α by human neutrophils after stimulation with different 
ligands, including 3pRNA. Compared to LPS and R848, which are 
known ligands to cause activation of human neutrophils, 3pRNA showed 
only marginal effect on the induction of TNF-α in human neutrophils 
(Figure 14).  
In addition to stimulation of neutrophils with the complexed RIG-I ligand, 
we treated human neutrophils directly with 3pRNA in absence of 
complexion with lipofectamine in order to declare that the low existence 
of RIG-I in the cytoplasm of human neutrophils didn’t result in the 
disability of activation by 3pRNA. However, we saw no activation of 
human neutrophils with the treatment of 3pRNA alone (Figure 16). 
Importantly, we confirmed colocalization of RIG-I on the cell surface and 
its ligand 3pRNA by confocal microscopy, excluding the possibility of 
early degradation of the RNA. 
 
4.2.5. Poly(I:C) and dsDNA had no effect on human neutrophils 
In the murine model, MDA5has been reported to be activated by poly(I:C) 
resulting in IFN production(Kato, Takeuchi et al. 2006). In our study, we 
stimulated human neutrophils with poly(I:C) and saw no activation. We 
did not compare these results to stimulation in the murine system, 
however, due to our findings in human cells and the findings of Kato et al. 
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in murine cells it is possible that neutrophils react differently to poly(I:C) 
for murine and human neutrophils.  
 
4.3. Clinical Significance of our Findings 
There is reasonable hope that the detection of small molecules capable 
of manipulating the human immune system will lead to some 
improvement of current adjuvant cancer therapies. This is especially true 
for such molecules that can simultaneously stimulate the immune 
system and cause genetic knock-down by RNA interference. A proof of 
principle of these molecules has been accomplished by Poeck et al. 
(Poeck, Besch et al. 2008). For many years it seemed that DNA based 
nucleotides stimulating TLR9 possessed sufficient potential for efficient 
anticancer vaccines; however the very encouraging results observed 
when treating murine tumors could unfortunately not be translated to 
human species. One of the reasons believed to be responsible for the 
poor efficiency of TLR9-ligands in the human species compared to the 
mouse is that while CpG-oligonucletoides can create a full blown TH1 
immune response in mice solely by stimulating TLR9; this is not the case 
in humans. For full TH1 immune response in humans including the 
induction of both key cytokines, IFN-αand IL12, additional stimulation of 
TLR7 or TLR8 on myeloid dendritic cells is necessary. Much hope arose 
when it was discovered that RNA based oligonucleotides possessed this 
potential by sequence specific activation of TLRs, including TLR7 and 
other cytosolic PRRs, such as RIG-I. The discovery that these molecules 
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may simultaneously be used not only for specific immune activation but 
also gene silencing by RNA interfering make these molecules a 
promising addition to future anticancer strategies. Obviously, despite 
their enormous potential, off-target effects must be avoided at all times in 
order to prevent uncontrolled overstimulation of the immune system and 
potential harm to the patient. In this study it was shown that 3pRNA did 
not lead to any off-target effects when intended to stimulate RIG-I on 
human neutrophils on a molecular and cellular level. In order to 
investigate if these encouraging results hold true in a more advanced 
and complex in vivo model and small molecules such as 3pRNA are safe 
to be use as therapeutics is to be established by further and intense 
investigation. 
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5. SUMMARY 
Neutrophils are typically the cells of the immune system to arrive earliest 
at the site of inflammation and infection. Due to their great number in 
peripheral blood and because these cells are equipped with a large 
variety of both regulatory and effective immune functions, they can 
significantly alter the course of an immune reaction. For example, human 
neutrophils are well known to express certain PRRs, and one of the 
PRRs is RIG-I. 3pRNA was recently described to be one physiologic 
ligand of cytosolic RIG-I. Activation of RIG-I by 3pRNA results in a direct 
induction of interferons (IFNs)and apoptosis in tumor cells.RNA based 
RIG-I ligands are currently under intense investigation for anticancer 
treatment strategies because it was discovered that such molecules 
could simultaneously cause specific gene knockdown of any desired 
gene, which creates huge potential for innovative therapeutic strategies 
toward a variety of infectious as well as inflammatory and tumorous 
diseases. 
How human neutrophils are affected by these new therapeutic 
approaches and whether there are potential off target effects is currently 
under investigation. Due to their central role during any immune 
response, activation of neutrophils during an artificial, therapeutic 
immune response would significantly limit the potential of RNA-based 
anticancer molecules.  
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Very little is known about the expression of PRRs in neutrophils, 
especially the newly discovered cytosolic PRRs, such as RIG-I, MDA5, 
and AIM2.The aim of this study was therefore to answer the following 
questions in order to help to clarify the role of neutrophils during 
immunostimulation with RNA based immunotherapeutics. 
1. If TLRs, MDA5, AIM2, and RIG-I are expressed in human neutrophils? 
If so, are they expressed on the cell surface or in the cytosol? 
2. Whether or no these important receptors in human neutrophils can 
be activated by immunostimulatory molecules? 
3. DMSO-treated HL60 cells have been reported to have similar 
characteristics with human neutrophils. Does this hold true for PRR 
expression profile, and do they serve as a convenient model for 
studying innate immune responses in human neutrophils? 
In this dissertation, we were able to obtain the following results: 
Human neutrophils showed expression of several TLRs, MDA5, AIM2, 
and RIG-I. However, the localization of RIG-I did not correspond with 
that of other cell types. While RIG-I has been described to be expressed 
in the cytosol, here we showed that in human but not murine neutrophils 
it is additionally expressed on the cell surface. We did not see any 
immunostimulatory effect of 3pRNA on human neutrophils, even though 
confocal microscopy confirmed binding of the ligand to RIG-I both at the 
cell surface and in the cytosol. 
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There are several significant differences in the expression profile of 
human neutrophils and untreated as well as DMSO-treated HL60 cells. 
Therefore, HL60 cells might not be an ideal model to study neutrophil 
innate immune mechanisms. 
Even though these results give some insight into how neutrophils react 
to certain ligands for PRR and their expression profile on these cells, 
further research is needed in order to determine the full spectrum of 
underlying mechanisms that are responsible for the complex interaction 
of neutrophils with RNA molecules, both in a physiologic and a 
therapeutic setting.  
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Summary in German (Zusammenfassung) 
Neutrophile Granulozyten sind Immunzellen, die vor allem dadurch 
charakterisiert sind, schnellstmöglich an einen Entzündungs- und 
Infektionsort zu gelangen. Auf Grund ihrer großen Anzahl im peripheren 
Blut und ihrer vielfältigen regulatorischen und effektiven 
Immunfunktionen können sie den Ablauf der Immunreaktion stark 
beeinflussen. Zum Beispielist bekannt, dass verschiedene PRRs auch in 
neutrophilen Granulozyten exprimiert werden. Mit RIG-I wurde kürzlich 
ein weiterer, wichtiger PRR beschrieben. Dieser Rezeptor befindet sich 
gewöhnlich im Zytosol einer Zelle und bindet dort virale RNA. 3pRNA 
konnte als ein spezifischer Ligand dieses Rezeptors identifiziert werden. 
Durch die Bindung der 3pRNA an RIG-I wird dieser Rezeptor aktiviert, 
und dieser Binding folgt eine direkte Induktion von Interferonen (IFNs). 
Auf RNA basierte Liganden von RIG-I und anderen PRRs stellen für 
zukünftige, moderne Tumortherapien einen interessanten Ansatz dar 
und werden derzeit intensiv beforscht.3pRNA Moleküle sind zusätzlich 
deshalb interessant, weil solche Moleküle neben immunstimulatorischen 
Eigenschaften zusätzlich ein spezifisches Gen-Knockdown induzieren 
können. Vor allem diese Kombination beinhaltet enormes Potential für 
innovative Therapiestrategien gegen verschiedene Infektionen, 
entzündlichen Erkrankungen, und Tumorerkrankungen. 
In welcher Weise humane neutrophile Granulozyten durch diese neuen 
therapeutischen Methoden beeinflusst werden und ob es potentielle 
Off-Target-Effekte durch Aktivierung dieser Zellen gibt, wird derzeit 
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durchdringend erforscht. Auf Grund ihrer zentralen Rolle in jeder 
Immunreaktion würde das Potential von RNA-basierten Anti-Tumor 
Molekülen signifikant begrenzt werden, wenn neben den eigentlichen 
Targetzellen auch Granulozyten während einer künstlichen 
therapeutischen Immunreaktion aktiviert werden würden. 
Noch ist wenig über die genaue Expression von PRRs in neutrophilen 
Granulozyten bekannt. Dies gilt besonders für die neu entdeckten 
intrazellulären PRRs, RIG-I, MDA5, und AIM2. Das Ziel dieser 
Doktorarbeit war es daher, die folgenden Fragen zu beantworten. 
Werden TLRs, MDA5, AIM2, und RIG-I in humanen neutrophilen 
Granulozyten exprimiert? Welcher subzellulären Lokalisation unterliegen 
sie? 
Im Fall einer signifikanten Expression erhebt sich zusätzlich die 
Fragestellung, ob diese Rezeptoren durch immunstimulatorische 
Moleküle aktiviert werden können. 
Für mit DMSO behandelte HL60 Zellen wurden beschrieben, das diese 
ähnliche Eigenschaften wie humane neutrophile Granulozyten besitzen. 
Daher war ferner die Fragestellung interessant, ob eine Ähnlichkeit des 
Profils der Expressionen von PRRs in dieser Zellreihe besteht und ob 
diese Zelle gegebenenfalls für Untersuchungen dieser Rezeptoren 
herangezogen werden kann. 
In dieser Dissertation haben wir die folgenden Ergebnisse erarbeiten 
können: 
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Humane neutrophile Granulozyten zeigten Expression von TLRs, MDA5, 
AIM2, und RIG-I. 
Interessanterweise entsprach die Lokalisation von RIG-I in humanen 
neutrophilen Granulozyten nicht der von anderen beschriebenen 
Zelltypen. Während RIG-I gewöhnlicherweise intrazellulär exprimiert 
wird, konnten wir hier zeigen, dass RIG-I in humanen neutrophilen 
Granulozyten aber nicht in murinen Granulozyten auf der Zellmembran 
exprimiert wird. 
Von besonderer Wichtigkeit ist, dass wir keinen immunstimulatorischen 
Effekt von 3pRNA auf humanen neutrophilen Granulozyten sahen, 
obwohl die intrazelluläre und membranöse Bindung von 3pRNA an RIG-I 
durch konfokale Mikroskopie bestätigt werden konnte. 
Darüber hinaus konnten wir zeigen, dass es klare Unterschiede 
zwischen der Expression von humanen neutrophilen Granulozyten, nicht 
behandelten und DMSO-behandelten HL60 Zellen gibt. Deshalb ist es 
eher unwahrscheinlich, dass HL60 Zellen als einwandfreie Zell-linie für 
die Erforschung von humanen PRRs zumindest in Granulozyten 
geeignet sind. 
Obwohl diese Ergebnisse einen guten Überblick darüber geben, wie 
neutrophile Granulozyten auf PRR-Ligande reagieren und wie deren 
Expressionsprofil bezüglich dieser Rezeptoren ist, sind weitere 
Untersuchung notwendig, um das komplette Spektrum unterliegender 
Mechanismen zu bestimmen, die für die komplexe Interaktion zwischen 
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neutrophilen Granulozyten und RNA Molekülen zuständig sind, sowohl 
im physiologischen als auch im therapeutischen Bereich. 
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Abbreviations and Acronyms 
3pRNA : triphosphate RNA 
AIM2 : absent in melanoma-2 
APC: allophycocyanin 
APC : antigen-presenting cells 
ASC : apoptosis- associated speck-like protein 
BCR : B cell receptor 
CARD : caspase recruitment domains 
CCR5 : C-C chemokine receptor type 5 
cDNA : complementary DNA 
DAPI : 4v,6-diamidino-2-phenylindole, dihydrochloride 
DMSO: dimethyl sulfoxide 
dNTPs : deoxyribonucleotide triphosphate 
dsDNA : double-stranded DNA 
dsRNA : double-stranded RNA 
DTT: dithiothreitol 
EDTA : ethylenediaminetetraacetic acid 
ELISA : enzyme-linked immunosorbent assay 
FACS : fluorescence activated cell sorting 
FBS: fetal bovine serum 
FITC: fluorescein isothiocyanate 
GM-CSF : granulocyte-macrophage colony-stimulating factor 
HEK : human embryonic kidney 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HIN-200 : hematopoietic interferon-inducible nuclear antigens with 200 
amino acid repeats 
HL60 cells : human promyelocytic leukemia cells 
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HLA : human leukocyte antigen 
Hsp 60 : heat shock protein 60 
IFN : inteferon 
IKK : IkappaB-related kinase 
IL-8 : interleukin 8 
isRNAs : immunstimulatory RNAs 
LAM : lipoarabinomannan 
LPS : lipopolysaccharides 
MALP-2 : macrophage-activating lipopeptide 2 
MAPK : mitogen-activated protein kinase 
MBL : mannan-binding lectin 
MDA5 : melanoma differentiation associated gene-5 
MFI ratio: mean fluorescence intensity ratio 
MHC : major histocompatibility complex 
mRNA : messenger RNA 
NGS : normal goat serum 
NHS-Fluorescein : fluorescein N-hydroxy-succinimidyl-ester 
NLRs : NOD-like receptors 
PAMPs : pathogen-associated molecular patterns 
PBS : phosphate buffered saline 
PCR: polymerase chain reaction 
PDCs : plasmacytoid dendritic cells 
PE: phycoerythrin 
PGRs : peptidoglycan recognition proteins 
PMA : phorbol-myristate-acetate 
Poly(dA-dT) ? Poly(dA-dT): poly(deoxyadenylic-thymidylic) acid sodium 
salt 
poly(I:C) : polyinosinic:polycytidylic acid 
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PRRs : pattern recognition receptors 
qPCR : quantitative PCR 
RHs : RNA helicases 
RIG-I : retinoic acid inducible gene I 
RNAi : RNA Interference 
RPMI : Roswell Park Memorial Institute 
siRNA : small interfering RNA 
ssRNA : single-stranded RNA 
TBK1 : TANK-binding kinase 1 
TBP: TATA-binding protein 
TCR : T cell receptor 
TLRs : Toll-like receptors 
TNF-? : tumor necrosis factor-alpha 
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